Rixubis
Jeneng umum: Coagulation Factor IX
Kelas obat:
Aneka modifikasi koagulasi
Panganggone Rixubis
Rixubis digunakake kanggo nambani utawa nyegah getihen ing wong hemofilia B. Obat iki ora kanggo nambani wong karo hemofilia A kurang faktor VIII.
Rixubis uga bisa digunakake kanggo tujuan ora kadhaptar ing pandhuan obat iki.
Rixubis efek sisih
Njaluk bantuan medis darurat yen sampeyan duwe tandha reaksi alergi: gatal-gatal, gatal; wheezing, sesak ing dhadha, angel ambegan, deg-degan cepet, lambe biru, krasa kaya sampeyan bisa mati; bengkak ing rai, lambe, ilat, utawa tenggorokan.
Rixubis bisa nyebabake efek samping sing serius. Hubungi dhokter sampeyan yen sampeyan duwe:
kelangan napsu;
Efek samping sing umum saka Rixubis bisa kalebu:
Iki dudu dhaftar lengkap efek sisih lan liyane bisa kelakon. Telpon dhokter kanggo saran medis babagan efek samping. Sampeyan bisa nglaporake efek samping menyang FDA ing 1-800-FDA-1088.
Sadurunge njupuk Rixubis
Sampeyan ora kudu nggunakake Rixubis yen:
Marang dhokter sampeyan yen sampeyan nate ngalami:
Marang dhokter yen sampeyan lagi ngandhut utawa nyusoni.
Rixubis digawe saka plasma manungsa sing disumbang lan bisa ngemot virus utawa agen infèksi liyane. Plasma sing disumbang diuji lan diobati kanggo nyuda risiko kontaminasi, nanging isih ana kemungkinan cilik bisa nularake penyakit. Takon dhokter sampeyan babagan risiko apa wae.
Related obat
- Advate
- Adynovate
- Adynovate recombinant
- Afstyla
- Afstyla recombinant
- Agrylin
- Alphanate
- Alphanine SD
- Alprolix
- Alprolix (Factor ix fc fusion protein recombinant Intravenous)
- Altuviiio
- Altuviiio (Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl Intravenous)
- Altuviiio (Antihemophilic factor Intravenous)
- Amicar
- Amicar (Aminocaproic acid Intravenous)
- Amicar (Aminocaproic acid Oral)
- Aminocaproic acid
- Aminocaproic acid (Intravenous)
- Aminocaproic acid (Oral)
- Anagrelide
- Anti-inhibitor coagulant complex
- Antihemophilic and von Willebrand factor complex
- Antihemophilic factor
- Antihemophilic factor (recombinant) pegylated-aucl
- Antihemophilic factor (recombinant) porcine sequence
- Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
- Antihemophilic factor (recombinant), glycopegylated-exei
- Antihemophilic factor human
- Antihemophilic factor recombinant
- Antihemophilic factor viii and von willebrand factor
- Artiss
- Artiss Duo Set
- Artiss Duploject
- Autoplex T
- Coagadex
- Coagulation factor IX
- Coagulation factor ix recombinant
- Coagulation factor ix recombinant, glycopegylated
- Coagulation factor viia
- Coagulation factor VIIa injection
- Coagulation factor viia-jncw
- Coagulation factor X
- Corifact
- Cyklokapron
- Bebulin VH
- BeneFIX
- Benefix (Coagulation factor ix recombinant Intravenous)
- Ceprotin
- Defibrotide
- Defitelio
- Eloctate
- Eloctate with Fc Fusion Protein recombinant
- Emicizumab
- Emicizumab-kxwh
- Esperoct (Antihemophilic factor (recombinant), glycopegylated-exei Intravenous)
- Esperoct (Antihemophilic factor Intravenous)
- Esperoct recombinant
- Evarrest
- Factor ix albumin fusion protein recombinant
- Factor IX complex
- Factor ix fc fusion protein recombinant
- Factor x human
- Factor XIII
- Feiba VH Immuno
- Feiba-VH
- Fibrin sealant topical
- Fibrinogen
- Fibrinogen and thrombin, human
- Fibrinogen/aprotinin and thrombin/calcium chloride
- Fostamatinib
- Fostamatinib disodium
- Helixate FS
- Helixate FS recombinant
- Hemlibra
- Hemofil-M
- Hemofil-M human
- Humate-P
- Hyate:C
- Idelvion
- Idelvion (Factor ix albumin fusion protein recombinant Intravenous)
- Ixinity
- Ixinity (Coagulation factor ix recombinant Intravenous)
- Jivi (Antihemophilic factor (recombinant) pegylated-aucl Intravenous)
- Jivi (Antihemophilic factor Intravenous)
- Jivi recombinant
- Koate DVI
- Koate-DVI human
- Kogenate FS
- Kogenate FS recombinant
- Kogenate FS with Adapter recombinant
- Kovaltry recombinant
- Lysteda
- Monoclate-P human
- Mononine
- Novoeight recombinant
- Novoseven
- NovoSeven RT
- NovoSeven RT with MixPro injection
- Nuwiq recombinant
- Obizur (Antihemophilic factor (recombinant) porcine sequence Intravenous)
- Obizur (Antihemophilic factor Intravenous)
- Pentopak
- Pentoxifylline
- Pentoxil
- Protein c, human
- Raplixa
- Rebinyn
- Rebinyn (Coagulation factor ix recombinant, glycopegylated Intravenous)
- Recombinate recombinant
- RiaSTAP
- Rixubis
- Rixubis (Coagulation factor ix recombinant Intravenous)
- Roctavian
- Tachosil
- Tavalisse
- Thrombin human, recombinant
- Tisseel
- Tisseel Duploject Kit
- Tisseel Valupak Kit
- Tranexamic acid
- Tranexamic acid (Intravenous)
- Tranexamic acid (Oral)
- Tranexamic acid Lysteda
- Trental
- Tretten
- Valoctocogene roxaparvovec-rvox
- Von Willebrand factor recombinant
- Vonvendi
- Wilate
- Xyntha
Carane nggunakake Rixubis
Tututi kabeh pituduh ing label resep lan waca kabeh pandhuan obat utawa lembar instruksi. Dokter sampeyan sok-sok ngganti dosis sampeyan. Gunakake obat kasebut persis kaya sing diarahake.
Sampeyan bisa nampa dosis pertama ing rumah sakit utawa klinik supaya bisa nambani efek samping sing serius.
Rixubis diwenehake minangka infus menyang vena. . Panyedhiya layanan kesehatan bakal menehi dosis pisanan lan bisa mulang sampeyan carane nggunakake obat kasebut kanthi bener.
Waca lan tututi kanthi ati-ati Pandhuan panggunaan sing diwenehake karo obat sampeyan. Takon dhokter utawa apoteker yen sampeyan ora ngerti kabeh instruksi.
Rixubis kudu dicampur karo cairan (diluent) sadurunge digunakake. Nalika nggunakake injeksi dhewe, priksa manawa sampeyan ngerti carane nyampur lan nyimpen obat kanthi bener.
Campuran kasebut kudu katon bening, kuning, utawa ora ana warna. Siapke injeksi mung nalika sampeyan wis siyap kanggo menehi. Aja nggunakake yen obat kasebut katon mendhung, wis ganti warna, utawa ana partikel ing njero. Telpon apoteker kanggo obat anyar.
Alon-alon muter nanging aja goyangake obat nalika nyampur utawa sampeyan bisa ngrusak obat kasebut. Gunakake injeksi sajrone 3 jam sawise nyampur dosis sampeyan.
Sampeyan mbutuhake tes getih sing kerep.
Yen ana darurat, nyandhang utawa nggawa identifikasi medis supaya wong liya ngerti yen sampeyan ngalami getihen. kelainan.
Tututi kanthi ati-ati pituduh ing label obat babagan cara nyimpen obat bubuk lan pengencer. Sawetara wangun faktor koagulasi IX bisa disimpen ing suhu kamar, lan liyane kudu disimpen ing kulkas. Aja beku. Aja ngedhunake obat marang cahya.
Saben vial (botol) mung kanggo siji panggunaan. Buang sawise siji nggunakake, sanajan isih ana obat ing njero.
Buang sisa Rixubis yen tanggal kadaluwarsa ing label wis liwati.
Gunakake jarum lan jarum suntik. mung sepisan banjur dilebokake ing wadhah "tajam" sing tahan tusukan. Tindakake hukum negara utawa lokal babagan cara mbuwang wadhah iki. Aja nganti tekan bocah lan kewan.
Pènget
Tututi kabeh pituduh ing label lan paket obat sampeyan. Marang saben panyedhiya kesehatan babagan kabeh kondisi medis, alergi, lan kabeh obat sing sampeyan gunakake.
Apa obatan liyane bakal mengaruhi Rixubis
Obat liyane bisa mengaruhi Rixubis, kalebu obat resep lan over-the-counter, vitamin, lan produk herbal. Marang dhokter sampeyan babagan kabeh obat sing saiki lan obat apa wae sing sampeyan wiwiti utawa mandheg nggunakake.
Disclaimer
Kabeh upaya wis ditindakake kanggo mesthekake yen informasi sing diwenehake dening Drugslib.com akurat, nganti -tanggal, lan lengkap, nanging ora njamin kanggo efek sing. Informasi obat sing ana ing kene bisa uga sensitif wektu. Informasi Drugslib.com wis diklumpukake kanggo digunakake dening praktisi kesehatan lan konsumen ing Amerika Serikat lan mulane Drugslib.com ora njamin sing nggunakake njaba Amerika Serikat cocok, kajaba khusus dituduhake digunakake. Informasi obat Drugslib.com ora nyetujoni obat, diagnosa pasien utawa menehi rekomendasi terapi. Informasi obat Drugslib.com minangka sumber informasi sing dirancang kanggo mbantu praktisi kesehatan sing dilisensi kanggo ngrawat pasien lan / utawa nglayani konsumen sing ndeleng layanan iki minangka tambahan, lan dudu pengganti, keahlian, katrampilan, kawruh lan pertimbangan babagan perawatan kesehatan. praktisi.
Ora ana bebaya kanggo kombinasi obat utawa obat sing diwenehake kanthi cara apa wae kudu ditafsirake kanggo nuduhake yen obat utawa kombinasi obat kasebut aman, efektif utawa cocok kanggo pasien tartamtu. Drugslib.com ora nanggung tanggung jawab kanggo aspek kesehatan apa wae sing ditindakake kanthi bantuan informasi sing diwenehake Drugslib.com. Informasi sing ana ing kene ora dimaksudake kanggo nyakup kabeh panggunaan, pituduh, pancegahan, bebaya, interaksi obat, reaksi alergi, utawa efek samping. Yen sampeyan duwe pitakon babagan obat sing sampeyan gunakake, takon dhokter, perawat utawa apoteker.
Tembung kunci populer
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions